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Endogenous cannabinoids (endocannabonoids) serve as retrograde messengers at 
synapses in various regions of the brain. They are released from postsynaptic neurons and 
cause transient and long-lasting reduction of neurotransmitter release through activation 
of presynaptic cannabonoid receptors. Endocannabinoid release is induced by either 
postsynaptic Ca2+ elevation or activation of Gq/11-coupled receptors. When these two 
stimuli coincide, endocanabinoid release is markedly enhanced, which is attributed to the 
Ca2+ dependency of phospholipase Cβ (PLCβ). This Ca2+-assisted receptor-driven 
endocannabinoid release is suggested to participate in various forms of synaptic plasticity, 
including short-term associative plasticity in the cerebellum and spike-timing dependent 
long-term depression in the somatosensory cortex. In these forms of plasticity, PLCβ 




At chemical synapses in the central nervous system, the signal is transmitted from 
presynaptic to postsynaptic neurons. The efficacy of this ‘anterograde’ transmission is 
modulated by a number of factors and also undergoes plastic change, which is thought to 
be important for brain functions including learning and memory [1]. In certain forms of 
synaptic plasticity, retrograde messengers, which are released from postsynaptic neurons 
and act on presynaptic terminals, have been postulated [2,3]. Recently, endogenous 
cannabinoids (endocannabinoids) have been found to function as retrograde messengers 
and contribute to synaptic modulation and plasticity [4-6]. Endocanabinoid-mediated 
retrograde modulation is now known to function at various types of synapses throughout 
the brain [7,8]. Our knowledge is rapidly expanding, concerning how the 
endocannabinoid signal is generated and contributes to short-term or long-term synaptic 
plasticity [7,8]. In this review, we highlight the significance of phospholipase Cβ (PLCβ) 
in generation of the endocannabinoid signal and discuss its roles in synaptic plasticity. 
 
Mechanisms underlying generation of endocannabinoid signal 
Endocannabinoid release triggered by postsynaptic depolarization 
In early 1990s, it was found that depolarization of a principal neuron transiently 
suppressed its inhibitory synaptic inputs in the cerebellum and hippocampus [2,3], and 
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this phenomenon was termed depolarization-induced suppression of inhibition (DSI). 
Further studies have revealed that DSI is mediated by retrograde messengers, which were 
finally identified as endocannabinoids in 2001 [4,5]. Concurrently, the counterpart of DSI 
at excitatory synapses, termed depolarization-induced suppression of excitation (DSE), 
was also confirmed to be mediated by endocannabinoids in the cerebellum [6]. Since then, 
a number of studies reported similar endocannabinoid-mediated DSI or DSE in various 
brain regions [7]. A current model of DSI/DSE is as follows (Fig. 1, red and black arrows). 
Postsynaptic depolarization causes a large intracellular Ca2+ elevation through 
voltage-gated Ca2+ channels [9] and triggers the biosynthesis of endocannabinoids. The 
endocannabinoids then diffuse out and activate presynaptic Gi/o-coupled type1 
cannabinoid receptors (CB1Rs).  It is postulated that cannabinoid receptor ligands 
incorporate into plasma membranes and interact with CB1Rs through fast lateral 
diffusion across the membrane lipid bilayer because of their lipophilic nature [10]. The 
CB1R activation causes a suppression of transmitter release in a reversible manner, 
through multiple mechanisms including modifications of Ca2+ channels, K+ channels and 
release machinery [11-13]. The Ca2+-induced Ca2+ release in postsynaptic neuron might 
be additionally involved at some synapses [14]. The peak value of Ca2+ elevation required 
for DSI/DSE is in a micromolar range [15,16] but can be lowered by sustaining Ca2+ 
elevation [17]. 2-Arachidonoylglycerol (2-AG), one of the two major endocannabinoids, 
is suggested to mediate DSI/DSE [18-21]. Biochemical studies indicate that 2-AG is 
produced from membrane lipids through two enzymatic reactions by PLC and 
diacylglycerol lipase (DGL), although some additional pathways are also available [22]. 
The involvement of DGL in DSI/DSE is supported by several studies [19-21], but not by 
some other studies [23-25]. There is no conclusive evidence showing the involvement of 
PLC in DSI/DSE.  
 
Endocannabinoid release triggered by Gq/11-coupled receptor activation 
Endocannabinoid-mediated retrograde modulation driven by Gq/11-coupled receptors was 
first found in the cerebellum [26]. The study demonstrated that activation of metabotropic 
glutamate receptor type 1 (mGluR1) in Purkinje cells (PCs) induced endocannabinoid 
release and caused suppression of excitatory transmission from climbing fibers (CFs) to 
PCs in cerebellar slices. Importantly, this modulation did not require Ca2+ elevation, 
indicating that the underlying mechanism is distinct from DSI/DSE. Since then, many 
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studies have reported similar endocananbinoid-mediated retrograde modulations driven 
by Gq/11-coupled receptors, which include group I mGluRs [27-31], M1/M3 muscarinic 
receptors [32,33], and the orexin receptor [34], in various brain regions. A current model 
for the receptor-driven endocannabinoid release is illustrated in Figure 1 (blue and black 
arrows) [7,8]. Activation of Gq/11-coupled receptors stimulates PLCβ and the enzymatic 
product diacylglycerol (DG) is then converted to 2-AG by DGL. Anatomical studies 
demonstrated that DGLα, one of the two isozymes of DGL, is localized on postsynaptic 
sites facing to CB1R-expressing terminals in the cerebellum and hippocampus, 
suggesting that these endocannabinoid system-related molecules are finely organized at 
synapses [35,36]. 
 
Combination of postsynaptic depolarization and receptor activation 
As described above, endocannabinoid release is induced by either depolarization or 
Gq/11-coupled receptor activation through distinct processes. However, when these two 
stimuli are combined, the endocannabinoid release is markedly facilitated [27,28,32,37]. 
Recent studies have revealed that PLCβ is the key molecule to detect the coincidence of 
the two stimuli [16,38]. The study using hippocampal neurons clearly demonstrated that 
the muscarinic receptor-driven endocannabinoid release required PLCβ1 and exhibited a 
sharp Ca2+ dependency within a physiological range. The muscarinic receptor-driven 
PLC activation, which was monitored by DG-sensitive TRPC6 channels, was also 
PLCβ1-dependent and exhibited a similar Ca2+ dependency. These results strongly 
suggest that PLCβ1 detects the coincidence through its Ca2+ dependency and induces 
2-AG synthesis in the hippocampus [38]. The study using cerebellar slices came to a 
similar conclusion [16]. The study showed that the mGluR1-driven endocannabinoid 
release was dependent on intracellular Ca2+ level, and that the enhanced endocannabinoid 
release by the combination of Ca2+ elevation and mGluR1 activation was abolished in 
PLCβ4-knockout mice. This PLCβ4-dependent enhancement of endocannabinoid release 
was induced by a submicromolar range of Ca2+ elevation, which was much lower than the 
level required for DSE [15,16]. The endocannabinoid release induced by simultaneous 
stimulation of small Ca2+ elevation and weak receptor activation has been termed 
Ca2+-assisted receptor-driven endoannabinoid release (Ca-RER) [16]. A current model 
for Ca-RER is included in Figure 1 (green, blue and black arrows). When the activation of 
Gq/11-coupled receptors coincides with Ca2+ elevation, PLCβ is effectively activated and 
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yields DG, which is then converted to 2-AG by DGL. It should be noted that the 
receptor-PLCβ signaling cascade may behave in a complicated manner due to the 
Ca2+-dependency of PLCβ. Under physiological conditions, it is known that the 
receptor-Gq/11-PLCβ signaling induces a Ca2+ elevation through inositol 
1,4,5-trisphosphate receptors (IP3R) or receptor-operated Ca2+-permeable channels 
(TRPC channels or some other Ca2+ entry channels). Therefore, the PLCβ signaling 
might be activated in a regenerative manner through the positive feedback loop between 
PLCβ and Ca2+ (Fig. 1, purple arrows). It is also likely that the receptor-PLCβ signaling 
may be influenced by preceding conditions that modulate the basal Ca2+ level or the 
filling state of Ca2+ stores.  
 
Functional significance of Ca2+-assisted receptor-driven 
endoannabinoid release in synaptic plasticity 
Recent studies have suggested that Ca-RER plays crucial roles in induction of 
endocannabinoid-mediated short-term or long-term plasticity. In the cerebellum, a brief 
burst of PF stimulation (for example, 50-100 Hz, 10 pulses), but not granular layer 
stimulation [39,40], induced endocannabinoid release from PCs and suppressed the 
transmitter release from PF terminals [16,41]. This type of synaptic suppression was 
dependent on both mGluR1 activation and postsynaptic Ca2+ elevation and abolished in 
PLCβ4-knockout mice [16], indicating the contribution of Ca-RER. A similar type of 
suppression induced by presynaptic firing alone is observed in local interneurons of the 
cerebellum [42] and dopamine neuron of the ventral tegmental area [43]. An associative 
type of short-term plasticity that involves Ca-RER was also found in the cerebellum. 
Brenowits and Regehr showed that coactivation of PF and CF markedly facilitated 
endocannabinoid-mediated suppression of PF synapses [44]. When PF stimulation was 
combined with CF stimulation (100 Hz, 5 pulses), only two to five pulses to PFs were 
enough to induce endocannabinoid release. This associative short-term plasticity was 
shown to be dependent on both mGluR1 activation and postsynaptic Ca2+ elevation. 
Ca-RER can also play a role in integrating the inputs of different neurotransmitters. 
Cholinergic inputs enhanced the depolarization-induced endocannabinoid release and 
augmented the suppression of GABAergic inputs in the hippocampus [32,38] and 
striatum [45]. Because the postsynaptic depolarization is generally evoked by 
glutamatergic inputs, PLCβ could play a role in integrating glutamatergic and cholinergic 
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inputs and modulating GABAergic inputs through the endocannabinoid signal in these 
neurons. 
 
There are several studies suggesting the involvement of Ca-RER in long-term plasticity, 
which includes cerebellar long-term depression (LTD) [24] and cortical 
spike-timing-dependent plasticity (STDP) [46,47]. Cerebellar LTD, which is induced by 
repeating conjunctive PF and CF stimulation, has been shown to require postsynaptic 
Ca2+ elevation and mGluR1 activation [48]. A recent study has demonstrated that 
cerebellar LTD requires 2-AG release and CB1R activation [24], suggesting that Ca-RER 
triggered by postsynaptic Ca2+ elevation and mGluR1 activation is involved in cerebellar 
LTD. STDP is induced by pre- and postsynaptic firings with a certain pre-to-post timing. 
At excitatory synapses in the sensory cortex, repeated presynaptic firing preceding 
postsynaptic firing by 0-20 ms generally induces long-term potentiation (tLTP), whereas 
pairing with the inverse timing induces long-term depression (tLTD). In a classical model 
of STDP, postsynaptic NMDA receptors (NMDARs) function as the sole coincidence 
detector for induction of both tLTP and tLTD [49,50]. Alternatively, two coincidence 
detector model for STDP is proposed [51], which is supported by recent studies. Bender 
et al. investigated STDP at excitatory layer 4 synapses on layer 2/3 (L2/3) pyramidal cells 
in somatosensory cortex [46]. They found that postsynaptic NMDARs were required for 
tLTP but not for tLTD, whereas mGluR5, voltage-gated Ca2+ channels, IP3R and CB1Rs 
were required for tLTD. Nevian and Sakmann reported that tLTD at basal dendrites of 
L2/3 pyramidal cells in the somatosensory cortex involved mGluR-PLC pathway and 
endocannabinoid signaling, but did not require postsynaptic NMDARs [47]. The authors 
proposed that mGluRs function as a postsynaptic switch, which determines the direction 
of STDP. Interestingly, these tLTDs is independent of postsynaptic NMDARs, but require 
non-postsynaptic (probably presynaptic) NMDAR activation, as reported at tLTD in 
visual cortex [52]. A presumed mechanism of endocannabinoid release for inducing tLTD 
is as follows. Postsynaptic firing causes a rise of postsynaptic Ca2+, which boosts the 
mGluR-PLCβ cascade driven by the subsequence presynaptic firing and effectively 




Mechanisms of terminating endocannabinoid signal 
The magnitude and time-course of endocannabinoid signaling is determined by the 
balance between the generation and degradation of endocannabinoids. The major 
endocannabinoid 2-AG is hydrolized by monoacylglycerol lipase (MGL) [53], which is 
localized at axon terminals [54]. It was originally reported that MGL is responsible for 
termination of hippocampal DSI by using a newly introduced MGL inhibitor, URB754 
[55]. However, later studies failed to confirm the effects of this compound on MGL 
activity and DSI [21,56,57]. This discrepancy was recently solved by the correction 
showing that the previously reported effects of URB754 are not caused by URB754 itself, 
but caused by some contaminated substances [58]. Instead of URB754, the contribution 
of MGL activity to terminating the endocannabinoid signal was confirmed by showing 
the prolongation of DSI/DSE by generally used MGL inhibitors [21,59]. Interestingly, it 
was found that these MGL inhibitors suppressed the basal synaptic transmission in a 
CB1-dependent manner [21], suggesting that 2-AG is constitutively released and 
degraded by presynaptic MGL even at basal conditions. The blockade of another 
endocannabinoid degradation enzyme, cyclooxygenase-2 (COX-2), also prolonged DSI 
[18]. In contrast to MGL, COX-2 was suggested to degrade 2-AG within postsynaptic 
neurons before it is released [18]. The termination mechanism of endocannabinoid signal 
is shown in Figure 1 (brown arrows).  
 
Conclusions and future directions 
After the first discovery of retrograde endocannabinoid signaling, a growing body of 
evidence has been presented that the endocannabinoid signal is widely used for induction 
of short-term and long-term synaptic plasticity throughout the brain. Although 
endocannabinoid release can be induced by multiple mechanisms, Ca-RER, which 
depends on both of PLCβ and Ca2+, seems most physiologically important. In this review, 
we introduced several studies suggesting that Ca-RER plays a crucial role in 
endocannabinoid-mediated synaptic plasticity, which is induced by presynaptic repetitive 
firing, associated activities of two distinct synaptic inputs, or combined pre- and 
postsynaptic firings with a certain pre-to-post timing. In either case, PLCβ appears to 
detect the coincidence of Ca2+ elevation and Gq/11-coupled receptor activation in the 
postsynaptic neuron and effectively generate the endocannabinoid signal, which then 
activates preysnaptic CB1Rs. It is not clear how presynaptic CB1R activation causes a 
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long-lasting change in transmitter release. In other forms of endocannabinoid-mediated 
LTD, a similar question still remains open. The downstream signaling cascades from 
CB1R activation to long-lasting modification of transmitter release should be determined 




This work was supported by Grants-in-Aid for Scientific Research 18-08582 (Y. H.), 
17650112, 17024021, and 18022016 (T.O-S.), 17023021, and 17100004 (M.K.) from the 
Ministry of Education, Culture, Sports, Science and Technology of Japan. Y.H is a 




1. Bliss TV, Collingridge GL: A synaptic model of memory: long-term potentiation in 
the hippocampus. Nature 1993, 361:31-39. 
2. Llano I, Leresche N, Marty A: Calcium entry increases the sensitivity of cerebellar 
Purkinje cells to applied GABA and decreases inhibitory synaptic currents. 
Neuron 1991, 6:565-574. 
3. Pitler TA, Alger BE: Postsynaptic spike firing reduces synaptic GABAA responses 
in hippocampal pyramidal cells. J Neurosci 1992, 12:4122-4132. 
4. Ohno-Shosaku T, Maejima T, Kano M: Endogenous cannabinoids mediate 
retrograde signals from depolarized postsynaptic neurons to presynaptic 
terminals. Neuron 2001, 29:729-738. 
5. Wilson RI, Nicoll RA: Endogenous cannabinoids mediate retrograde signalling at 
hippocampal synapses. Nature 2001, 410:588-592. 
6. Kreitzer AC, Regehr WG: Retrograde inhibition of presynaptic calcium influx by 
endogenous cannabinoids at excitatory synapses onto Purkinje cells. Neuron 
2001, 29:717-727. 
7. Chevaleyre V, Takahashi KA, Castillo PE: Endocannabinoid-mediated synaptic 
plasticity in the CNS. Annu Rev Neurosci 2006, 29:37-76. 
8. Hashimotodani Y, Ohno-Shosaku T, Kano M: Endocannabinoids and synaptic 
function in the CNS. Neuroscientist 2007, in press. 
9. Rancz EA, Hausser M: Dendritic calcium spikes are tunable triggers of 
cannabinoid release and short-term synaptic plasticity in cerebellar Purkinje 
neurons. J Neurosci 2006, 26:5428-5437. 
10. Makriyannis A, Tian X, Guo J: How lipophilic cannabinergic ligands reach their 
receptor sites. Prostaglandins Other Lipid Mediat 2005, 77:210-218. 
11. Twitchell W, Brown S, Mackie K: Cannabinoids inhibit N- and P/Q-type calcium 
channels in cultured rat hippocampal neurons. J Neurophysiol 1997, 
78:43-50. 
12. Daniel H, Crepel F: Control of Ca(2+) influx by cannabinoid and metabotropic 
glutamate receptors in rat cerebellar cortex requires K(+) channels. J Physiol 
2001, 537:793-800. 
13. Yamasaki M, Hashimoto K, Kano M: Miniature synaptic events elicited by 
presynaptic Ca2+ rise are selectively suppressed by cannabinoid receptor 
 9
activation in cerebellar Purkinje cells. J Neurosci 2006, 26:86-95. 
14. Isokawa M, Alger BE: Ryanodine receptor regulates endogenous cannabinoid 
mobilization in the hippocampus. J Neurophysiol 2006, 95:3001-3011. 
15. Brenowitz SD, Regehr WG: Calcium dependence of retrograde inhibition by 
endocannabinoids at synapses onto Purkinje cells. J Neurosci 2003, 
23:6373-6384. 
16. Maejima T, Oka S, Hashimotodani Y, Ohno-Shosaku T, Aiba A, Wu D, Waku K, 
Sugiura T, Kano M: Synaptically driven endocannabinoid release requires 
Ca2+-assisted metabotropic glutamate receptor subtype 1 to phospholipase 
Cbeta4 signaling cascade in the cerebellum. J Neurosci 2005, 25:6826-6835. 
17. Brenowitz SD, Best AR, Regehr WG: Sustained elevation of dendritic calcium 
evokes widespread endocannabinoid release and suppression of synapses 
onto cerebellar Purkinje cells. J Neurosci 2006, 26:6841-6850. 
18. Kim J, Alger BE: Inhibition of cyclooxygenase-2 potentiates retrograde 
endocannabinoid effects in hippocampus. Nat Neurosci 2004, 7:697-698. 
19. Straiker A, Mackie K: Depolarization-induced suppression of excitation in 
murine autaptic hippocampal neurones. J Physiol 2005, 569:501-517. 
20. Szabo B, Urbanski MJ, Bisogno T, Di Marzo V, Mendiguren A, Bar W, Freiman I: 
Depolarization-induced retrograde synaptic inhibition in the cerebellar 
cortex is mediated by 2-arachidonoylglycerol. J Physiol 2006, 577:263-280. 
21. Hashimotodani Y, Ohno-Shosaku T, Kano M: Presynaptic monoacylglycerol lipase 
activity determines basal endocannabinoid tone and terminates retrograde 
endocannabinoid signaling in the hippocampus. J Neurosci 2007, in press. 
22. Sugiura T, Kishimoto S, Oka S, Gokoh M: Biochemistry, pharmacology and 
physiology of 2-arachidonoylglycerol, an endogenous cannabinoid receptor 
ligand. Prog Lipid Res 2006, 45:405-446. 
23. Chevaleyre V, Castillo PE: Heterosynaptic LTD of hippocampal GABAergic 
synapses: a novel role of endocannabinoids in regulating excitability. Neuron 
2003, 38:461-472. 
24. Safo PK, Regehr WG: Endocannabinoids control the induction of cerebellar LTD. 
Neuron 2005, 48:647-659. 
25. Edwards DA, Kim J, Alger BE: Multiple mechanisms of endocannabinoid 
response initiation in hippocampus. J Neurophysiol 2006, 95:67-75. 
 10
26. Maejima T, Hashimoto K, Yoshida T, Aiba A, Kano M: Presynaptic inhibition 
caused by retrograde signal from metabotropic glutamate to cannabinoid 
receptors. Neuron 2001, 31:463-475. 
27. Varma N, Carlson GC, Ledent C, Alger BE: Metabotropic glutamate receptors 
drive the endocannabinoid system in hippocampus. J Neurosci 2001, 
21:RC188. 
28. Ohno-Shosaku T, Shosaku J, Tsubokawa H, Kano M: Cooperative endocannabinoid 
production by neuronal depolarization and group I metabotropic glutamate 
receptor activation. Eur J Neurosci 2002, 15:953-961. 
29. Galante M, Diana MA: Group I metabotropic glutamate receptors inhibit GABA 
release at interneuron-Purkinje cell synapses through endocannabinoid 
production. J Neurosci 2004, 24:4865-4874. 
30. Kushmerick C, Price GD, Taschenberger H, Puente N, Renden R, Wadiche JI, 
Duvoisin RM, Grandes P, von Gersdorff H: Retroinhibition of presynaptic 
Ca2+ currents by endocannabinoids released via postsynaptic mGluR 
activation at a calyx synapse. J Neurosci 2004, 24:5955-5965. 
31. Narushima M, Hashimoto K, Kano M: Endocannabinoid-mediated short-term 
suppression of excitatory synaptic transmission to medium spiny neurons in 
the striatum. Neurosci Res 2006, 54:159-164. 
32. Kim J, Isokawa M, Ledent C, Alger BE: Activation of muscarinic acetylcholine 
receptors enhances the release of endogenous cannabinoids in the 
hippocampus. J Neurosci 2002, 22:10182-10191. 
33. Fukudome Y, Ohno-Shosaku T, Matsui M, Omori Y, Fukaya M, Tsubokawa H, Taketo 
MM, Watanabe M, Manabe T, Kano M: Two distinct classes of muscarinic 
action on hippocampal inhibitory synapses: M2-mediated direct suppression 
and M1/M3-mediated indirect suppression through endocannabinoid 
signaling. Eur J Neurosci 2004, 19:2682-2692. 
34. Haj-Dahmane S, Shen RY: The wake-promoting peptide orexin-B inhibits 
glutamatergic transmission to dorsal raphe nucleus serotonin neurons 
through retrograde endocannabinoid signaling. J Neurosci 2005, 25:896-905. 
35. Yoshida T, Fukaya M, Uchigashima M, Miura E, Kamiya H, Kano M, Watanabe M: 
Localization of diacylglycerol lipase-alpha around postsynaptic spine 
suggests close proximity between production site of an endocannabinoid, 
 11
2-arachidonoyl-glycerol, and presynaptic cannabinoid CB1 receptor. J 
Neurosci 2006, 26:4740-4751. 
36. Katona I, Urban GM, Wallace M, Ledent C, Jung KM, Piomelli D, Mackie K, Freund 
TF: Molecular composition of the endocannabinoid system at glutamatergic 
synapses. J Neurosci 2006, 26:5628-5637. 
37. Ohno-Shosaku T, Matsui M, Fukudome Y, Shosaku J, Tsubokawa H, Taketo MM, 
Manabe T, Kano M: Postsynaptic M1 and M3 receptors are responsible for 
the muscarinic enhancement of retrograde endocannabinoid signalling in 
the hippocampus. Eur J Neurosci 2003, 18:109-116. 
38. Hashimotodani Y, Ohno-Shosaku T, Tsubokawa H, Ogata H, Emoto K, Maejima T, 
Araishi K, Shin HS, Kano M: Phospholipase Cbeta serves as a coincidence 
detector through its Ca2+ dependency for triggering retrograde 
endocannabinoid signal. Neuron 2005, 45:257-268. 
39. Marcaggi P, Attwell D: Endocannabinoid signaling depends on the spatial pattern 
of synapse activation. Nat Neurosci 2005, 8:776-781. 
40. Marcaggi P, Attwell D: Short- and long-term depression of rat cerebellar parallel 
fibre synaptic transmission mediated by synaptic crosstalk. J Physiol 2007, 
578:545-550. 
41. Brown SP, Brenowitz SD, Regehr WG: Brief presynaptic bursts evoke 
synapse-specific retrograde inhibition mediated by endogenous 
cannabinoids. Nat Neurosci 2003, 6:1048-1057. 
42. Beierlein M, Regehr WG: Local interneurons regulate synaptic strength by 
retrograde release of endocannabinoids. J Neurosci 2006, 26:9935-9943. 
43. Melis M, Perra S, Muntoni AL, Pillolla G, Lutz B, Marsicano G, Di Marzo V, Gessa 
GL, Pistis M: Prefrontal cortex stimulation induces 
2-arachidonoyl-glycerol-mediated suppression of excitation in dopamine 
neurons. J Neurosci 2004, 24:10707-10715. 
44. Brenowitz SD, Regehr WG: Associative short-term synaptic plasticity mediated 
by endocannabinoids. Neuron 2005, 45:419-431. 
45. Narushima M, Uchigashima M, Fukaya M, Matsui M, Manabe T, Hashimoto K, 
Watanabe M, Kano M: Tonic Enhancement of Endocannabinoid-Mediated 
Retrograde Suppression of Inhibition by Cholinergic Interneuron Activity in 
the Striatum. J Neurosci 2007, 27:496-506. 
 12
46. Bender VA, Bender KJ, Brasier DJ, Feldman DE: Two coincidence detectors for 
spike timing-dependent plasticity in somatosensory cortex. J Neurosci 2006, 
26:4166-4177. 
47. Nevian T, Sakmann B: Spine Ca2+ signaling in spike-timing-dependent plasticity. 
J Neurosci 2006, 26:11001-11013. 
48. Ito M: Cerebellar long-term depression: characterization, signal transduction, 
and functional roles. Physiol Rev 2001, 81:1143-1195. 
49. Dan Y, Poo MM: Spike timing-dependent plasticity of neural circuits. Neuron 
2004, 44:23-30. 
50. Shouval HZ, Bear MF, Cooper LN: A unified model of NMDA receptor-dependent 
bidirectional synaptic plasticity. Proc Natl Acad Sci U S A 2002, 
99:10831-10836. 
51. Karmarkar UR, Buonomano DV: A model of spike-timing dependent plasticity: 
one or two coincidence detectors? J Neurophysiol 2002, 88:507-513. 
52. Sjostrom PJ, Turrigiano GG, Nelson SB: Neocortical LTD via coincident activation 
of presynaptic NMDA and cannabinoid receptors. Neuron 2003, 39:641-654. 
53. Dinh TP, Carpenter D, Leslie FM, Freund TF, Katona I, Sensi SL, Kathuria S, 
Piomelli D: Brain monoglyceride lipase participating in endocannabinoid 
inactivation. Proc Natl Acad Sci U S A 2002, 99:10819-10824. 
54. Gulyas AI, Cravatt BF, Bracey MH, Dinh TP, Piomelli D, Boscia F, Freund TF: 
Segregation of two endocannabinoid-hydrolyzing enzymes into pre- and 
postsynaptic compartments in the rat hippocampus, cerebellum and 
amygdala. Eur J Neurosci 2004, 20:441-458. 
55. Makara JK, Mor M, Fegley D, Szabo SI, Kathuria S, Astarita G, Duranti A, Tontini A, 
Tarzia G, Rivara S, et al.: Selective inhibition of 2-AG hydrolysis enhances 
endocannabinoid signaling in hippocampus. Nat Neurosci 2005, 8:1139-1141. 
56. Saario SM, Palomaki V, Lehtonen M, Nevalainen T, Jarvinen T, Laitinen JT: URB754 
Has No Effect on the Hydrolysis or Signaling Capacity of 2-AG in the Rat 
Brain. Chem Biol 2006, 13:811-814. 
57. Vandevoorde S, Jonsson KO, Labar G, Persson E, Lambert DM, Fowler CJ: Lack of 
selectivity of URB602 for 2-oleoylglycerol compared to anandamide 
hydrolysis in vitro. Br J Pharmacol 2007, 150:186-191. 
58. Makara JK, Mor M, Fegley D, Szabo SI, Kathuria S, Astarita G, Duranti A, Tontini A, 
 13
Tarzia G, Rivara S, et al.: Selective inhibition of 2-AG hydrolysis enhances 
endocannabinoid signaling in hippocampus. Nat Neurosci 2007, 10:134. 
59. Szabo B, Urbanski MJ, Bisogno T, Di Marzo V, Mendiguren A, Baer WU, Freiman I: 
Depolarization-induced retrograde synaptic inhibition in the mouse 





 16• (Maejima et al., 2005) 
This study shows that mGluR1-driven endocananbinoid release requires PLCβ4 and is 
enhanced by intracellular Ca2+ elevation in cerebellular PCs. The study also 
demonstrates that this Ca2+-assisted mGluR1-PLCβ4 cascade is essential for 
endocannabinoid release triggered by a short train of PF stimulation. Furthermore, 
the authors show convincingly by biochemical analysis that combination of weak 
mGluR1 activation and mild depolarization in PCs effectively induces 2-AG 
production in a PLCβ4-dependent manner.   
 
35• (Yoshida et al., 2006) 
This study demonstrates subcellular localization of DGLα in the cerebellum and 
hippocampus. Anatomical data indicate that in the cerebellum, DGLα is 
predominantly expressed in PCs and is concentrated at the base of spine neck and 
somatodendritic surface but not in the spine head. By contrast, in the hippocampal 
pyramidal cells, DGLα is distributed in either spine head or neck or both. By 
examining anatomical relationship of DGLα distribution with other 
endocannabinoid signaling molecules including mGluR1, PLCβ4 and CB1R, the 
authors show that these elements are finely organized at excitatory synapses. 
 
36• (Katona et al., 2006) 
This paper also shows the localization of DGLα in the hippocampus. In situ hybridization 
analysis shows that principal neurons express high levels of DGLα mRNA 
throughout the hippocampal formation. Immunostaining data indicate that DGLα 
is concentrated in the spine heads of principal neurons. This study also shows that 
CB1Rs are located on the glutamatergic presynaptic terminals opposite to the 
DGLα-expressing postsynaptic site. 
 
38•• (Hashimotodani et al., 2005) 
This study demonstrates that endocannabinoid release driven by group I mGluR or 
muscarinic receptors in hippocampal neurons requires PLCβ1 and exhibits a 
sharp Ca2+ dependence within a physiological range. The study shows that 
combination of muscarinic receptor activation and depolarization markedly 
facilitates endocannabinoid release in a PLCβ1-dependent manner and the timing 
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of two stimuli is critical for this enhancement. Using DG-sensitive TRPC6 
channels as a real-time monitor of PLC activity, the authors confirm that 
muscarinic receptor-driven PLCβ1 activation exhibits the same Ca2+-dependency, 
and conclude that PLCβ1 serves as a coincidence detector of Ca2+ elevation and 
Gq/11-coupled receptor activation for induction of endocannabinoid release. 
 
44•• (Brenowitz et al., 2005) 
In this paper, the authors demonstrate that endocannabinoid release evoked by PF 
stimulation is greatly enchanced by coactivation of CF synapses in cerebellar PCs. 
The authors suggest that this short-term form of associative synaptic plasticity 
involves two mechanisms. First, PF-induced mGluR1 activation reduces the Ca2+ 
requirement of endocannabinoid release. Second, PF and CF coactivation induces 
supralinear dendritic calcium transients. 
 
46•• (Bender et al., 2006) 
This study supports the two coincidence detector model for STDP. The study shows that 
in the somatosensory cortex spike-timing-dependent LTP requires postsynaptic 
NMDARs, whereas LTD requires mGluR5, Ca2+ influx through voltage-gated 
Ca2+ channels, IP3Rs, retrograde endocannabinoid signaling, and 
non-postsyanptic, probably presynaptic NMDARs. 
 
47•• (Nevian & Sakmann, 2006) 
This study also supports the two coincidence detector model for STDP. The authors 
demonstrate that spike-timing-dependent LTD requires postsynaptic Ca2+ 
elevation, activation of mGluRs and PLC, and endocannabinoid signaling, but not 
postsynaptic NMDARs. Importantly, this study shows that the amplitude of spine 
Ca2+ increase is not correlated to the direction of plasticity (LTP or LTD). The 
authors suggest that mGluR-coupled signaling cascade is important for 





Schematic models of retrograde endocannabinoid signaling. Strong postsynaptic 
depolarization causes large intracellular Ca2+ elevation, which induces DG 
production through unknown pathways (red arrows).  Activation of Gq-coupled 
receptor stimulates PLCβ and yields DG (blue arrows). When Gq-coupled 
receptor activation coincides with mild Ca2+ elevation induced by weak 
postsynaptic depolarization (green arrows), DG is produced more effectively than 
without Ca2+ elevation because of the Ca2+ dependency of PLCβ. Another PLCβ 
product, IP3, might facilitate the receptor-PLCβ signaling by releasing Ca2+ from 
endoplasmic reticulum (ER) through IP3Rs (purple arrows).  DG is then converted 
to 2-AG through DGL activity (black arrow). 2-AG is released, binds to 
presynaptic CB1Rs, probably through fast lateral diffusion across the membrane 
lipid bilayer, and causes suppression of neurotransmitter release. Degradation of 
2-AG is mediated by postsynaptic COX-2 and presynaptic MGL activity (brown 
arrows). In this scheme, synapse is generalized and not specified as either 
excitatory or inhibitory. PI, phosphatidylinositol; VGCC, voltage-gated Ca2+ 
channel. 
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